• 1. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
• 2. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 3. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 4. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 5. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Hydroxy fatty acids
• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Fatty acids and conjugates Hydroxy fatty acids

(2S,3S)-Viridifloric Acid (CAS No. 17132-48-8): An Overview of Its Structure, Properties, and Applications in Chemical and Biological Research

(2S,3S)-Viridifloric Acid (CAS No. 17132-48-8) is a naturally occurring compound that has garnered significant attention in the fields of chemistry and biology due to its unique structural features and potential biological activities. This compound, first isolated from the plant Daphne genkwa, has been the subject of numerous studies aimed at elucidating its chemical properties and biological effects. This article provides a comprehensive overview of (2S,3S)-Viridifloric Acid, including its chemical structure, physical properties, biosynthetic pathways, and recent advancements in its applications.

Chemical Structure and Physical Properties

(2S,3S)-Viridifloric Acid is a diterpenoid compound with a molecular formula of C₂₀H₃₀O₅. Its molecular weight is approximately 350.45 g/mol. The compound features a complex structure with multiple chiral centers, which contribute to its unique stereochemistry. The presence of these chiral centers results in the formation of enantiomers, which can have different biological activities. The specific enantiomer discussed here is the (2S,3S) configuration, which has been shown to exhibit significant biological activity.

In terms of physical properties, (2S,3S)-Viridifloric Acid is a white crystalline solid at room temperature. It is soluble in organic solvents such as methanol and ethanol but has limited solubility in water. The compound has a melting point of around 185-187°C and is stable under normal laboratory conditions. These properties make it suitable for various analytical and preparative techniques.

Biosynthetic Pathways and Natural Sources

The biosynthesis of (2S,3S)-Viridifloric Acid involves a series of enzymatic reactions that occur in plants such as Daphne genkwa. The primary precursor for the biosynthesis of this compound is geranylgeranyl diphosphate (GGPP), which undergoes cyclization to form the basic diterpenoid skeleton. Subsequent oxidation and functional group modifications lead to the formation of (2S,3S)-Viridifloric Acid. Understanding these biosynthetic pathways is crucial for the development of biotechnological methods to produce this compound on a larger scale.

Natural sources of (2S,3S)-Viridifloric Acid include various species within the genus Daphne, particularly Daphne genkwa. These plants are native to East Asia and have been used in traditional medicine for centuries due to their diverse pharmacological properties. The isolation and purification of (2S,3S)-Viridifloric Acid from these natural sources have been extensively studied using techniques such as column chromatography and high-performance liquid chromatography (HPLC).

Biological Activities and Applications

(2S,3S)-Viridifloric Acid has been investigated for its potential biological activities, including anti-inflammatory, antioxidant, and anticancer properties. Recent studies have shown that this compound exhibits significant anti-inflammatory effects by inhibiting the production of pro-inflammatory cytokines such as TNF-α and IL-6. Additionally, it has been found to possess potent antioxidant activity by scavenging free radicals and reducing oxidative stress.

In the context of cancer research, (2S,3S)-Viridifloric Acid has demonstrated promising anticancer effects against various cancer cell lines. Studies have shown that it can induce apoptosis in cancer cells by modulating key signaling pathways such as the PI3K/Akt pathway and the MAPK pathway. These findings suggest that (2S,3S)-Viridifloric Acid could be a potential candidate for the development of novel anticancer drugs.

Beyond its direct biological activities, (2S,3S)-Viridifloric Acid has also been explored for its potential applications in drug delivery systems. Due to its unique chemical structure and physical properties, it can be incorporated into various nanocarriers to enhance its bioavailability and therapeutic efficacy. This approach has shown promise in improving the delivery of other bioactive compounds and reducing their side effects.

Current Research Trends and Future Perspectives

The ongoing research on (2S,3S)-Viridifloric Acid is focused on several key areas. One major area of interest is the elucidation of its mechanism of action at the molecular level. Advanced techniques such as X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy are being used to gain insights into how this compound interacts with specific cellular targets.

Another important area of research is the optimization of synthetic methods for producing (2S,3S)-Viridifloric Acid strong>. While natural sources provide a viable option for small-scale production, there is a growing need for efficient synthetic routes that can meet the demands of large-scale applications. Recent advancements in asymmetric synthesis have shown promise in achieving high yields and enantiomeric purity.

In addition to these technical challenges, there is also a need for further clinical studies to evaluate the safety and efficacy of (2S,3S)-Viridifloric Acid strong> in humans. Preclinical studies have provided encouraging results, but more comprehensive clinical trials are required to validate these findings and explore potential therapeutic applications.

Conclusion strong> p > < p >In conclusion ,< strong >( 2 S , 3 S ) - Viridifloric Acid strong > ( CAS No . 17132 - 48 - 8 ) is a multifaceted compound with significant potential in chemical and biological research . Its unique chemical structure , coupled with its diverse biological activities , makes it an intriguing subject for further investigation . As research continues to advance , it is likely that new applications for this compound will be discovered , contributing to advancements in drug discovery , drug delivery systems , and other areas of biotechnology . p > article > < / response >

• 5949-29-1(Citric acid monohydrate)
• 6100-05-6(Potassium citrate monohydrate)
• 10402-15-0(Copper Citrate)
• 866-83-1(Potassium Citrate Monobasic)
• 77-92-9(Citric acid)
• 77-95-2(D(-)-Quinic Acid)
• 3012-65-5(Diammonium hydrogen citrate)
• 1123-28-0(1-Hydroxycyclohexanecarboxylic acid)
• 6205-14-7(Hydroxycitric Acid (Technical Grade))
• 7778-49-6(Potassium citrate)